大量的非小细胞肺癌用两场强大的质子网增强治疗,然后用常规化学辐射治疗
Matthew J Ferris1, Sina Mossahebi1, Jenna Jatczak1
1Department of Radiation Oncology, University of Maryland School of Medicine, United States.
Clinical and translational radiation oncology
|July 4, 2025
概括
新的质子疗法技术显示出对管理庞大的非小细胞肺癌 (NSCLC) 的承诺. 一种空间分成的笔束扫描 (PBS) 提高了两名患者的受控瘤,为难以治疗的肺癌提供了一种新方法.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 在瘤学瘤学.
背景情况:
- 地方性复发仍然是非小细胞肺癌 (NSCLC) 的挑战,尽管辅助免疫治疗的进展.
- 大量的NSCLC通常需要创新的治疗策略来改善局部控制.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


